ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,784 | -7.3% | 66,178 | +45.4% | 0.00% | -20.0% |
| Q2 2023 | $226,284 | +6.5% | 45,530 | +5.9% | 0.01% | 0.0% |
| Q1 2023 | $212,420 | +53.5% | 43,000 | +95.5% | 0.01% | +25.0% |
| Q4 2022 | $138,380 | -70.2% | 22,000 | -48.8% | 0.00% | -69.2% |
| Q3 2022 | $464,000 | -5.3% | 43,000 | 0.0% | 0.01% | -13.3% |
| Q2 2022 | $490,000 | +25.0% | 43,000 | 0.0% | 0.02% | +66.7% |
| Q1 2022 | $392,000 | -38.9% | 43,000 | 0.0% | 0.01% | -40.0% |
| Q4 2021 | $642,000 | -42.0% | 43,000 | -0.1% | 0.02% | -48.3% |
| Q3 2021 | $1,106,000 | -1.3% | 43,047 | +0.1% | 0.03% | -12.1% |
| Q2 2021 | $1,121,000 | -26.2% | 43,000 | 0.0% | 0.03% | -47.6% |
| Q1 2021 | $1,518,000 | +39.9% | 43,000 | 0.0% | 0.06% | +31.2% |
| Q4 2020 | $1,085,000 | -33.1% | 43,000 | 0.0% | 0.05% | -44.8% |
| Q3 2020 | $1,622,000 | -11.9% | 43,000 | 0.0% | 0.09% | -26.9% |
| Q2 2020 | $1,841,000 | +120.2% | 43,000 | 0.0% | 0.12% | +77.6% |
| Q1 2020 | $836,000 | -25.2% | 43,000 | 0.0% | 0.07% | -31.6% |
| Q4 2019 | $1,117,000 | – | 43,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |